MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Eye Cancer : vimarsana.com

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Eye Cancer

MediciNova Receives Notice of Allowance for New Patent Covering MN-166 (ibudilast) for the Prevention of Metastasis of Eye Cancer
tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Tokyo , Japan , Davidh Crean , Kazuko Matsuda , Nasdaq , Uveal Melanoma In Molecular Cancer Research , Medicinova Inc , Exchange Commission , Trademark Office , Nova Receives Notice , New Patent Covering , Standard Market , Tokyo Stock Exchange , Code Number , Chief Medical Officer , Medicinova Announces New Data , Uveal Melanoma Presented , Medicinova Announces Publication , Uveal Melanoma , Molecular Cancer , Private Securities Litigation Reform Act ,